Thom R. Loree, MD, FACS | Authors


Differentiated Thyroid Carcinoma: Risk Group Assignment and Management Controversies

January 01, 1998

In this review, we provide a framework for clinical decision-making in the treatment of differentiated thyroid cancer. The clinical discussion and treatment recommendations are relevant to an adult population (more than 16